Temodar Safety Questions, Temodar Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Temodar side effects. Check out Health Surveys and Health Polls. If you have questions about Temodar, you can post them to our Doctors or Ask Patient Community about Temodar.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Temodar
Temodar Safety Reports
Total Temodar reports: 218.Temodar FDA safety alerts: No.
Reported deaths: 70 Reported hospitalizations: 133.
Take Temodar Side Effects Survey or Share Your Temodar Story.
Reported Temodar Side Effects: pancytopenia, dehydration, death, disease progression, thrombocytopenia, platelet count decreased, pneumonia, fatigue, asthenia, white blood cell count decreased, bone marrow failure.
More About Temodar.
Showing 1-50 of 218 Next >
Temodar Side Effects Report #5329942-XHealth Professional from UNITED STATES reported TEMODAR problem on May 17, 2007. Male patient, 65 years of age, weighting 156.0 lb, was diagnosed with malignant melanoma and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: atelectasis, disease progression, dyspnoea exertional, haemoglobin decreased, metastases to lung, oxygen saturation decreased, platelet count decreased, pleural effusion. TEMODAR dosage: 140MG,QD,FOR 6 WKS. During the same period patient was treated with VELCADE, COENZYME Q, OMEGA, VITA K AND C, FLOMAX, LASIX, COMBINVENT. Patient died on 05/14/2007.
Temodar Side Effects Report #5331668-3
TEMODAR problem was reported by a Health Professional from UNITED STATES on May 09, 2007. Female patient, 65 years of age, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia. TEMODAR dosage: 20 MG; QD; PO. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5331669-5
Physician from UNITED STATES reported TEMODAR problem on May 11, 2007. Male patient, 72 years of age, weighting 257.5 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: asthenia, cerebral haemorrhage, diarrhoea, dyspnoea, lung infiltration, melaena, musculoskeletal pain, neutrophil count decreased, oedema peripheral. TEMODAR dosage: 170 MG; QD; PO. During the same period patient was treated with HUMALOG, LASIX, ZOCOR, COZAAR, GLUCOPHAGE, ADVIL. Patient was hospitalized. Patient died on 05/02/2007.
Temodar Side Effects Report #5331714-7
TEMODAR problem was reported by a Consumer or non-health professional from UNITED STATES on May 04, 2007. Male patient, 43 years of age, was diagnosed with brain neoplasm and was treated with TEMODAR. TEMODAR dosage: 150 MG;QM;PO. Patient died on 04/01/2007.
Temodar Side Effects Report #5331878-5
Health Professional from UNITED STATES reported TEMODAR problem on May 11, 2007. Male patient, 27 years of age, was diagnosed with brain neoplasm and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: thrombosis. TEMODAR dosage: 170 MG;QD;PO. Patient recovered.
Temodar Side Effects Report #5336316-4
TEMODAR problem was reported by a Physician from UNITED STATES on May 17, 2007. Female patient, 75 years of age, weighting 137.0 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: blood sodium decreased, depressed level of consciousness, neutrophil count decreased, platelet count decreased, somnolence. TEMODAR dosage: 5040 MG; PO. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5336630-2
Physician from UNITED STATES reported TEMODAR problem on May 17, 2007. Female patient, 68 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with TEMODAR. TEMODAR dosage: 200 MG; QD. Patient died on 02/01/2007.
Temodar Side Effects Report #5339881-6
TEMODAR problem was reported by a Pharmacist from UNITED STATES on May 18, 2007. Male patient, 69 years of age, was treated with TEMODAR. TEMODAR dosage: unknown. Patient died on 01/01/2007.
Temodar Side Effects Report #5339907-X
Physician from UNITED STATES reported TEMODAR problem on May 17, 2007. Male patient, 85 years of age, was diagnosed with malignant melanoma and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: dehydration, disease progression, oral intake reduced. TEMODAR dosage: 140 MG; QD. Patient was hospitalized. Patient died on 05/16/2007.
Temodar Side Effects Report #5341751-4
TEMODAR problem was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2007. Female patient, weighting 122.1 lb, was diagnosed with oligodendroglioma and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: cognitive disorder, disease progression. TEMODAR dosage: 150MG/M2 DAYS 1-5 PO. During the same period patient was treated with LEXAPRO, RITALIN LA, KEPPRA, ZOFRAN, PHENERGAN. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5345340-7
Physician from UNITED STATES reported TEMODAR problem on May 25, 2007. Male patient, 85 years of age, was diagnosed with malignant melanoma and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: dehydration, disease progression, eating disorder. TEMODAR dosage: 140 MG; QD. Patient was hospitalized. Patient died on 05/16/2007.
Temodar Side Effects Report #5347103-5
TEMODAR problem was reported by a Health Professional from UNITED STATES on May 25, 2007. Female patient, 52 years of age, was diagnosed with brain neoplasm malignant and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: fatigue. TEMODAR dosage: 100 MG; HS. Patient died.
Temodar Side Effects Report #5350398-5
Health Professional from UNITED STATES reported TEMODAR problem on June 05, 2007. Male patient, weighting 156.0 lb, was diagnosed with metastases to central nervous system and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: diverticular perforation. TEMODAR dosage: 175 MG QD PO. Patient was hospitalized. Patient died on 06/03/2007.
Temodar Side Effects Report #5353810-0
TEMODAR problem was reported by a Health Professional from UNITED STATES on June 08, 2007. Male patient, 82 years of age, weighting 133.8 lb, was diagnosed with metastatic malignant melanoma and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: idiopathic thrombocytopenic purpura. TEMODAR dosage: 200 MG QD X 5 Q21 DAYS PO. Patient recovered.
Temodar Side Effects Report #5362016-0
Physician from UNITED STATES reported TEMODAR problem on June 12, 2007. Male patient, 85 years of age, weighting 339.5 lb, was diagnosed with metastatic malignant melanoma and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: dehydration, disease progression, malignant melanoma, oral intake reduced. TEMODAR dosage: 140 MG; QD;. Patient was hospitalized. Patient died on 05/16/2007.
Temodar Side Effects Report #5364379-9
TEMODAR problem was reported by a Pharmacist from UNITED STATES on June 10, 2007. Male patient was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic. TEMODAR dosage: unknown. Patient recovered.
Temodar Side Effects Report #5364382-9
Physician from UNITED STATES reported TEMODAR problem on June 14, 2007. Female patient, 59 years of age, weighting 174.6 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pneumonitis. TEMODAR dosage: 190 MG; QD; PO. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5371577-7
TEMODAR problem was reported by a Health Professional from UNITED STATES on June 19, 2007. Male patient, 69 years of age, was diagnosed with brain neoplasm and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: disease progression, fall, pelvic fracture. TEMODAR dosage: 375 MG; QD; PO. Patient died on 06/16/2007.
Temodar Side Effects Report #5372540-2
Physician from UNITED STATES reported TEMODAR problem on June 15, 2007. Male patient, 46 years of age, was diagnosed with malignant melanoma and was treated with TEMODAR. TEMODAR dosage: 400 MG; PO. Patient died.
Temodar Side Effects Report #5374080-3
TEMODAR problem was reported by a Consumer or non-health professional from UNITED STATES on June 18, 2007. Male patient, 64 years of age, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism, thrombosis. TEMODAR dosage: 160 MG;QD;PO. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5374716-7
Health Professional from UNITED STATES reported TEMODAR problem on June 27, 2007. Male patient, weighting 156.0 lb, was diagnosed with metastases to central nervous system and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: diverticular perforation, large intestine perforation. TEMODAR dosage: 175 MG Q.D. PO. Patient was hospitalized. Patient died on 06/03/2007.
Temodar Side Effects Report #5049256-5
TEMODAR problem was reported by a Health Professional from UNITED STATES on June 29, 2006. Female patient was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia. TEMODAR dosage: unknown. Patient recovered.
Temodar Side Effects Report #5051746-6
Physician from UNITED STATES reported TEMODAR problem on June 26, 2006. Male patient, 50 years of age, weighting 189.6 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: chills, deep vein thrombosis, febrile neutropenia, fungal rash, oedema peripheral, stomatitis. TEMODAR dosage: 150 MG DAY ORAL. During the same period patient was treated with DILANTIN, MEPRON, DECADRON, PRILOSEC, COLACE. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5055179-8
TEMODAR problem was reported by a Physician from UNITED STATES on July 03, 2006. Male patient, 69 years of age, weighting 205.0 lb, was diagnosed with oligodendroglioma and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: erythema multiforme, neoplasm progression, pneumonia, stevens-johnson syndrome. TEMODAR dosage: 160 MG QD ORAL. During the same period patient was treated with DECADRON, LAMICTAL, DEPAKOTE, KEPPRA, NEURONTIN. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5060052-5
Physician from UNITED STATES reported TEMODAR problem on July 11, 2006. Female patient was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: hepatotoxicity. TEMODAR dosage: unknown. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5060314-1
TEMODAR problem was reported by a Physician from UNITED STATES on July 11, 2006. Male patient, 77 years of age, was diagnosed with metastatic malignant melanoma and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, disease progression, mental status changes, metastases to central nervous system, parkinson's disease. TEMODAR dosage: 75 MG/M2DI-42 ORAL. During the same period patient was treated with SORAFENIB. Patient was hospitalized. Patient died on 07/09/2006.
Temodar Side Effects Report #5062242-4
Physician from GERMANY reported TEMODAR problem on July 11, 2006. Male patient, 58 years of age, weighting 180.8 lb, was diagnosed with metastatic malignant melanoma and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: pneumonia, pulmonary oedema. TEMODAR dosage: 300 MG ORAL. Patient was hospitalized. Patient died on 07/04/2006.
Temodar Side Effects Report #5063047-0
TEMODAR problem was reported by a Physician from UNITED STATES on July 14, 2006. Male patient, 69 years of age, weighting 205.0 lb, was diagnosed with oligodendroglioma and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: erythema multiforme, lung disorder, neoplasm progression, nonspecific reaction, pneumonia, stevens-johnson syndrome. TEMODAR dosage: 160 MG QD ORAL. During the same period patient was treated with DECADRON, LAMICTAL, DEPAKOTE, KEPPRA, NEURONTIN. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5066726-4
Physician from UNITED STATES reported TEMODAR problem on July 18, 2006. Female patient, 74 years of age, was diagnosed with glioblastoma, glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, atrial fibrillation, bone marrow failure, escherichia infection, hypotension, hypoventilation, hypoxia, ischaemic hepatitis, liver function test abnormal. TEMODAR dosage: 75 MG/M2 ORAL. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5066732-X
TEMODAR problem was reported by a Health Professional from UNITED STATES on July 18, 2006. Female patient, weighting 100.0 lb, was diagnosed with central nervous system lymphoma and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: bone pain, dizziness, dry skin, fall, gait disturbance, haematoma, headache, incorrect dose administered, joint swelling. TEMODAR dosage: unknown. During the same period patient was treated with LEVOTHYROXIN. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5068152-0
Consumer or non-health professional from UNITED STATES reported TEMODAR problem on July 21, 2006. Male patient was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. TEMODAR dosage: unknown. Patient was hospitalized. Patient died.
Temodar Side Effects Report #5073419-6
TEMODAR problem was reported by a Physician from UNITED STATES on July 26, 2006. Female patient, 58 years of age, weighting 202.0 lb, was diagnosed with astrocytoma and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: hepatitis. TEMODAR dosage: 145 MG QD ORAL. During the same period patient was treated with PEPCID, SENOKOT, LORTAB. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5074498-2
Health Professional from UNITED STATES reported TEMODAR problem on July 26, 2006. Female patient, 71 years of age, weighting 180.0 lb, was diagnosed with astrocytoma and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, epistaxis. TEMODAR dosage: 300 MG QD X5D ORAL. During the same period patient was treated with TOPROL, KYTRIL. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5081435-3
TEMODAR problem was reported by a Physician from UNITED STATES on Aug 02, 2006. Male patient, 74 years of age, weighting 187.4 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: large intestine perforation, small intestinal obstruction. TEMODAR dosage: 150 MG QD ORAL. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5082607-4
Physician from UNITED STATES reported TEMODAR problem on Aug 03, 2006. Male patient, 82 years of age, was diagnosed with metastatic malignant melanoma, metastases to central nervous system and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: asthenia, dehydration, diverticulitis, gastrointestinal perforation, oral intake reduced. TEMODAR dosage: 150 MG/M2D1-5 ORAL. During the same period patient was treated with SORAFENIB. Patient was hospitalized. Patient died.
Temodar Side Effects Report #5084288-2
TEMODAR problem was reported by a Physician from UNITED STATES on Aug 08, 2006. Female patient was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: abasia, nervous system disorder. TEMODAR dosage: unknown. Patient recovered.
Temodar Side Effects Report #5084298-5
Health Professional from UNITED STATES reported TEMODAR problem on Aug 08, 2006. Female patient, 77 years of age, weighting 218.0 lb, was diagnosed with metastatic malignant melanoma and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, colitis, dehydration, diarrhoea, diverticulum intestinal, dry mouth, fatigue, hypovolaemia. TEMODAR dosage: 315MGQDX7Q ORAL. During the same period patient was treated with SUNITINIB MALATE, SKELAXIN, DIOVAN, CLARINEX, MOBIC, NEXIUM, INDAPAMIDE, PEPCID. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5086835-3
TEMODAR problem was reported by a Physician from UNITED STATES on Aug 14, 2006. Male patient, 74 years of age, weighting 187.4 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: large intestine perforation, refusal of treatment by relative, small intestinal obstruction. TEMODAR dosage: 1500 MG QD ORAL. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5086849-3
Physician from UNITED STATES reported TEMODAR problem on Aug 11, 2006. Male patient, 74 years of age, weighting 165.3 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, confusional state, constipation, urinary retention. TEMODAR dosage: 200 MG/M^2 QD ORAL. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5087945-7
TEMODAR problem was reported by a Physician from UNITED STATES on Aug 16, 2006. Male patient, 74 years of age, weighting 165.3 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: chills, confusional state, constipation, pyrexia, tremor, urinary retention. TEMODAR dosage: 200 MG/M^2 QD ORAL. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5091504-X
Physician from UNITED STATES reported TEMODAR problem on Aug 21, 2006. Male patient, 74 years of age, weighting 187.4 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, large intestine perforation, muscle spasms, small intestinal obstruction. TEMODAR dosage: 150 MG QD ORAL. Patient was hospitalized. Patient died on 08/20/2006.
Temodar Side Effects Report #5091553-1
TEMODAR problem was reported by a Physician from UNITED STATES on Aug 18, 2006. Male patient was diagnosed with brain neoplasm and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: cardiac arrest. TEMODAR dosage: unknown. Patient died.
Temodar Side Effects Report #5091555-5
Physician from UNITED STATES reported TEMODAR problem on Aug 16, 2006. Male patient was diagnosed with brain neoplasm and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. TEMODAR dosage: 75 MG/M2 ORAL. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5107351-6
TEMODAR problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 21, 2006. Female patient, 68 years of age, weighting 134.0 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia, jaw disorder, mass, neutropenia, oral candidiasis, pancytopenia, thrombocytopenia. TEMODAR dosage: 125 MG; QD; PO. During the same period patient was treated with KEPPRA, DECADRON, GLUCOPHAGE, MIRALAX, DIFLUCAN, MAGIG MOUTH WASH, ZOFRAN. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5109420-3
Consumer or non-health professional from UNITED STATES reported TEMODAR problem on Aug 28, 2006. Female patient, 56 years of age, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: blister infected, blood blister, blood disorder, full blood count decreased, incorrect dose administered. TEMODAR dosage: unknown. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5109423-9
TEMODAR problem was reported by a Physician from UNITED STATES on Sept 08, 2006. Male patient, 70 years of age, weighting 176.6 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: confusional state, hypoxia, lung infiltration, lymphopenia, mental status changes, pneumonia, pneumonitis, procedural complication, pulmonary embolism. TEMODAR dosage: 75 MG/M2;QD;PO. During the same period patient was treated with REGULAR INSULIN, METFORMIN, DECADRON. Patient was hospitalized. Patient died on 08/30/2006.
Temodar Side Effects Report #5113267-1
Consumer or non-health professional from UNITED STATES reported TEMODAR problem on Sept 06, 2006. Male patient was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: erythema multiforme. TEMODAR dosage: 140 MG;QD;PO. Patient recovered.
Temodar Side Effects Report #5114775-X
TEMODAR problem was reported by a Health Professional from UNITED STATES on Sept 07, 2006. Male patient, 38 years of age, weighting 179.9 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: dehydration, hypoalbuminaemia, hypocalcaemia, hypokalaemia, hypophosphataemia, vomiting. TEMODAR dosage: 200 MG/M2;QD;PO. During the same period patient was treated with IMATINIB MESYLATE, CONCERTA. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5115621-0
Physician from UNITED STATES reported TEMODAR problem on Sept 11, 2006. Female patient, 29 years of age, was diagnosed with brain neoplasm and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome. TEMODAR dosage: unknown. Patient recovered.
Temodar Side Effects Report #5121275-X
TEMODAR problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 21, 2006. Male patient, 76 years of age, was diagnosed with glioblastoma and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: abasia, confusional state, disorientation, facial palsy, fall, muscle rigidity, pyrexia. TEMODAR dosage: 140 MG; QD; PO; SEE IMAGE. Patient recovered.
Showing 1-50 of 218 Next >
Drug Information: Temozolomide
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a601250.html
(te moe zoe' loe mide)About your treatment
Your doctor has ordered the drug temozolomide to help treat your illness. This medication is used to treat brain tumors (astrocytoma). The drug is taken by mouth in capsule form. Your full dose may contain two or more different strengths of temozolomide capsules. Take your dose at bedtime, with a full glass of water, on an empty stomach. Do not chew or open the capsules. If a capsule opens or breaks, be careful not to get the contents on the skin around your eyes, nose, or mouth. Temozolomide is usually given once daily for 5 days. The treatment may be repeated every 28 days.
This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Temozolomide is in a class of drugs known as imidazotetrazine derivatives. It slows or stops the growth of cancer cells in your body. The length of treatment depends on how well your body responds to the treatment.
Precautions
Before taking temozolomide,
- tell your doctor and pharmacist if you are allergic to temozolomide, dacarbazine, or any other drugs.
- tell your doctor and pharmacist what prescription and nonprescription medications you are taking, including herbal products and vitamins.
- tell your doctor if you have or have ever had kidney or liver disease.
- you should not plan to have children while receiving chemotherapy or for a while after treatments. (Talk to your doctor for further details.) Use a reliable method of birth control to prevent pregnancy. Temozolomide may harm the fetus.
- tell your doctor if you are breast-feeding.
- do not have any vaccinations (e.g., measles or flu shots) without talking to your doctor.
- be aware that temozolomide has been associated with the development of other types of cancer. Talk to your doctor about the potential risk of developing a new cancer.
Side effects
Side effects from temozolomide are common and include:
- nausea
- vomiting
- diarrhea
- stomach pain and cramps
- headache
- numbness
- weakness
- tiredness
- back pain
- dizziness
- difficulty walking or coordinating movement
- vision changes
- loss of appetite
- fever
- swelling of the hands, feet, ankles, or lower legs
- weight gain
- constipation
- discoloration of the skin
- hair loss
- nose bleeds
- fatigue
- confusion
- anxiety
- difficulty falling or staying asleep
- urinary incontinence
- breast pain in women
If you experience any of the following symptoms, call your doctor immediately:
- unusual bleeding or bruising
- rash
- itching
- difficulty breathing or swallowing
- seizures
- infection
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/index.html] or by phone [1-800-332-1088].
Storage conditions
Keep temozolomide in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
Brand name(s):
|